226 related articles for article (PubMed ID: 25902443)
21. alpha-Synuclein misfolding: single molecule AFM force spectroscopy study.
Yu J; Malkova S; Lyubchenko YL
J Mol Biol; 2008 Dec; 384(4):992-1001. PubMed ID: 18948117
[TBL] [Abstract][Full Text] [Related]
22. Early sodium dodecyl sulfate induced collapse of α-synuclein correlates with its amyloid formation.
Basak S; Prasad GV; Varkey J; Chattopadhyay K
ACS Chem Neurosci; 2015 Feb; 6(2):239-46. PubMed ID: 25369246
[TBL] [Abstract][Full Text] [Related]
23. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
Jiang C; Chang JY
Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
[TBL] [Abstract][Full Text] [Related]
24. Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.
Tsigelny IF; Sharikov Y; Kouznetsova VL; Greenberg JP; Wrasidlo W; Overk C; Gonzalez T; Trejo M; Spencer B; Kosberg K; Masliah E
ACS Chem Neurosci; 2015 Mar; 6(3):403-16. PubMed ID: 25561023
[TBL] [Abstract][Full Text] [Related]
25. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
Fredenburg RA; Rospigliosi C; Meray RK; Kessler JC; Lashuel HA; Eliezer D; Lansbury PT
Biochemistry; 2007 Jun; 46(24):7107-18. PubMed ID: 17530780
[TBL] [Abstract][Full Text] [Related]
26. Dimeric structures of alpha-synuclein bind preferentially to lipid membranes.
Giannakis E; Pacífico J; Smith DP; Hung LW; Masters CL; Cappai R; Wade JD; Barnham KJ
Biochim Biophys Acta; 2008 Apr; 1778(4):1112-9. PubMed ID: 18261456
[TBL] [Abstract][Full Text] [Related]
27. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
[TBL] [Abstract][Full Text] [Related]
28. Binding of Cu(II) to human alpha-synucleins: comparison of wild type and the point mutations associated with the familial Parkinson's disease.
Hong L; Simon JD
J Phys Chem B; 2009 Jul; 113(28):9551-61. PubMed ID: 19548659
[TBL] [Abstract][Full Text] [Related]
29. Molecular Dynamics Study to Investigate the Dimeric Structure of the Full-Length α-Synuclein in Aqueous Solution.
Zhang T; Tian Y; Li Z; Liu S; Hu X; Yang Z; Ling X; Liu S; Zhang J
J Chem Inf Model; 2017 Sep; 57(9):2281-2293. PubMed ID: 28796507
[TBL] [Abstract][Full Text] [Related]
30. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.
Hoyer W; Cherny D; Subramaniam V; Jovin TM
Biochemistry; 2004 Dec; 43(51):16233-42. PubMed ID: 15610017
[TBL] [Abstract][Full Text] [Related]
31. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
[TBL] [Abstract][Full Text] [Related]
32. The alpha-synuclein mutation E46K promotes aggregation in cultured cells.
Pandey N; Schmidt RE; Galvin JE
Exp Neurol; 2006 Feb; 197(2):515-20. PubMed ID: 16325180
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.
Albani D; Peverelli E; Rametta R; Batelli S; Veschini L; Negro A; Forloni G
FASEB J; 2004 Nov; 18(14):1713-5. PubMed ID: 15345691
[TBL] [Abstract][Full Text] [Related]
34. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
[TBL] [Abstract][Full Text] [Related]
35. Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids.
Zarbiv Y; Simhi-Haham D; Israeli E; Elhadi SA; Grigoletto J; Sharon R
Neurobiol Dis; 2014 Oct; 70():90-8. PubMed ID: 24905915
[TBL] [Abstract][Full Text] [Related]
36. Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study.
Curtain CC; Kirby NM; Mertens HD; Barnham KJ; Knott RB; Masters CL; Cappai R; Rekas A; Kenche VB; Ryan T
Mol Biosyst; 2015 Jan; 11(1):190-6. PubMed ID: 25352253
[TBL] [Abstract][Full Text] [Related]
37. α-Synuclein dimer structures found from computational simulations.
Sahu KK; Woodside MT; Tuszynski JA
Biochimie; 2015 Sep; 116():133-40. PubMed ID: 26193124
[TBL] [Abstract][Full Text] [Related]
38. Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine.
Jain MK; Bhat R
Neurobiol Dis; 2014 Mar; 63():115-28. PubMed ID: 24269918
[TBL] [Abstract][Full Text] [Related]
39. Distinct hydration properties of wild-type and familial point mutant A53T of α-synuclein associated with Parkinson's disease.
Hazy E; Bokor M; Kalmar L; Gelencser A; Kamasa P; Han KH; Tompa K; Tompa P
Biophys J; 2011 Nov; 101(9):2260-6. PubMed ID: 22067166
[TBL] [Abstract][Full Text] [Related]
40. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
